09 December 2021
We're now open for consultation on our myositis guideline and we'd love to hear your comments; you can feed back until 5pm on 23 December. This guideline provides clinicians, for the first time, with evidence-based recommendations on management of patients with idiopathic inflammatory myopathy.
The guideline addresses a wide range of topics including remission induction, remission maintenance, management of extra-muscular manifestations and mental wellbeing.
The guideline provides recommendations for paediatric, adolescent, and adult idiopathic inflammatory myositis patients, recognising similarities and differences between the populations.
This guideline helps standardise care for all patients with idiopathic inflammatory myositis and allows audit assessment using the corresponding tool.
Myositis guideline and associated documents
Myositis guideline consultation form
Submit comments